Nav: Home

Current Statins News and Events

Current Statins News and Events, Statins News Articles.
Sort By: Most Relevant | Most Viewed
Page 1 of 24 | 945 Results
Lowering cholesterol is not enough to reduce hyperactivity of the immune system
Despite treatment with statins, many patients with elevated cholesterol levels will still develop cardiovascular disease. (2019-06-13)
The surprising role fibrinogen plays in regulating the body's response to disease
A finding from University of Alberta researchers is shining new light on the role fibrinogen has in regulating a natural defence mechanism in the body. (2019-06-11)
Early statin treatment may help children with Fragile X
Children with an inherited form of intellectual disability and autism could be helped by a medicine commonly used to lower cholesterol, if used early in life, research from the University of Edinburgh suggests. (2019-05-29)
Long-term health effects of armed conflict could last years after bombs stop falling
Living in a warzone is linked with an increased risk of heart attack and stroke among civilians, even years after the conflict ends, a study has found. (2019-05-28)
Life-threatening genetic cholesterol condition could be found through blood donations
Blood donation programs represent a unique opportunity as a public health portal to screen for diseases. (2019-05-22)
Statins' potential to treat MS unrelated to lowering cholesterol
The widely prescribed statin, simvastatin, can medically help patients with secondary progressive Multiple Sclerosis (SPMS) -- for reasons that might be unrelated to the drug's intended cholesterol lowering affects, a UCL study has found. (2019-05-10)
Statins linked to lower risk of early death in patients with colorectal cancer
Use of statins before or after a diagnosis of colorectal cancer was linked with a lower risk of premature death, both from cancer and from other causes, in a Cancer Medicine analysis of published studies. (2019-05-09)
Study shows one third of statin patients don't reach healthy levels of 'bad' cholesterol
Using electronic health records from the Indiana Network for Patient Care, a new population health study of entire state found that one third of statin patients don't reach healthy levels of 'bad' cholesterol. (2019-05-09)
Study looks at association of high cholesterol levels, statin use with glaucoma risk
A study of adults 40 and older suggests high cholesterol levels are associated with increased risk for the most common form of glaucoma, while longer use of a cholesterol-lowering statin, compared with never using, was associated with lower risk. (2019-05-02)
People with heart disease at risk when pharmacies close
New research shows that when pharmacies close, people stop taking widely used heart medications -- like statins, beta-blockers and oral anticoagulants -- that have known cardiovascular and survival benefits. (2019-04-19)
Pharmacy closures associated with declines in cardiovascular medication adherence
How pharmacy closures are associated with declines in cardiovascular medication adherence for statins, β-blockers and oral anticoagulants among adults 50 or older was the focus of this analysis of prescription claims. (2019-04-19)
Late dinner and no breakfast is a killer combination
People who skip breakfast and eat dinner near bedtime have worse outcomes after a heart attack. (2019-04-18)
Statins safe for preventing cardiovascular events in rheumatoid arthritis patients
Results from a large clinical trial indicate that patients with rheumatoid arthritis are likely to experience the same level of cardiovascular benefits from statins as other individuals, without additional risks. (2019-04-15)
The screen interval for high cardiovascular disease risk should be individual
According to a study published today by a Finnish-English research group, a switch from 5-yearly screen intervals to individualized intervals could annually prevent 8 percent of myocardial infarcts and strokes without increasing health care costs. (2019-04-03)
Patients say lack of physician guidance and fear of side effects are why they don't take statins as prescribed
Despite national guidelines indicating that statins can lower risk of heart attack and stroke, many patients who could benefit do not take them. (2019-03-27)
Study explaining side effects of statins finds drug can have unexpected benefits
By suppressing the activity of key cellular receptors called G protein-coupled receptors (GPCRs) and their interacting partners called G proteins, statins have the potential to alter various bodily functions controlled by this important pathway, according to researchers at The University of Toledo. (2019-03-19)
Icosapent ethyl drug reduces risk of recurrent cardiovascular events
Further insights from the REDUCE-IT trial show that high-dose, pure and stable EPA omega 3 drug not only reduces the burden of first cardiovascular events but also subsequent and total heart attacks, strokes, and other measures. (2019-03-18)
Statin add-on may offer new/another option for reducing LDL-C in high-risk patients
Patients at high risk for a heart attack or stroke who took an investigational drug in addition to a statin had significantly lower LDL, or 'bad' cholesterol, after 12 weeks compared to similar patients who took a placebo in addition to statin therapy, according to research presented at the American College of Cardiology's 68th Annual Scientific Session. (2019-03-18)
Taking statins for heart disease cuts risk in half, yet only 6 percent of patients taking as directed
Study finds that taking statins for heart disease cuts risk of second serious event in half, yet only 6 percent of patients are following as directed. (2019-03-16)
Cholesterol-lowering drugs guard against brain haemorrhages
The drugs statins, which are used to prevent cardiovascular diseases, also guard against brain haemorrhages. (2019-03-14)
New cholesterol-lowering drug could help patients unable to take statins
A new class of oral cholesterol-lowering drug could help patients unable to take statins due to side effects. (2019-03-13)
Heart attacks increasingly common in young adults
Even though fewer heart attacks are occurring in the US -- in large part due to the use of medications like statins and a decline in smoking -- these events are steadily rising in very young adults. (2019-03-07)
Statins linked to higher diabetes risk
Individuals who take cholesterol-lowering statins may be at higher risk for developing high blood sugar levels, insulin resistance, and eventually type 2 diabetes, according to an analysis published in the British Journal of Clinical Pharmacology. (2019-03-06)
CT scans offer clues to preventing heart problems after cancer treatment
An imaging procedure commonly performed before starting cancer treatment can provide valuable clues about a patient's risk for heart problems in the months and years after treatment. (2019-03-06)
Professor Mary Schooling analyzes the relationship between testosterone and serious heart conditions
To explore whether there is a strong association between testosterone and the development of heart disease, CUNY SPH Professor Mary Schooling led a study using a technique called Mendelian randomization to analyze genetic variants that predict testosterone levels and their associations with blood clots, heart failure and heart attack in almost 400,000 men and women from a large genetic study and the UK Biobank study. (2019-03-06)
10 percent of Chinese adults have high heart disease risk, aren't treated for it
Researchers at Yale and at the National Center for Cardiovascular Disease in China just quantified a significant opportunity to improve Chinese heart health: 1 in 10 middle-aged Chinese adults are at high risk for heart disease, yet only about 3 percent of those at-risk are taking either statins or aspirin, the recommended therapies for managing that risk. (2019-02-21)
Study finds low statin use among some high-risk kidney disease patients
Cholesterol-lowering statin drugs reduce the risk of cardiovascular disease in kidney disease patients who are not on dialysis. (2019-02-18)
The Lancet: Statin therapy reduces risk of major cardiovascular events irrespective of age
Statin therapy reduces major vascular events, and a new meta-analysis shows this is the case even in patients over 75 years of age. (2019-01-31)
Untangling tau: researchers find a 'druggable target' for treating Alzheimer's disease
Using induced pluripotent stem cell-derived neurons from Alzheimer's patients, UC San Diego researchers say cholesteryl esters -- the storage product for excess cholesterol within cells -- act as regulators of the protein tau, providing a new druggable target for the disease. (2019-01-24)
Widely used physical health drugs may help treat serious mental illness
Medications commonly used to combat physical health diseases, such as high blood pressure, could bring significant benefits to people with serious mental illnesses (SMI) such as schizophrenia, bipolar disorder or non-affective psychoses, according to a large cohort study led by UCL. (2019-01-09)
Familial hypercholesterolemia in children and adolescents: diagnosis and treatment
Familial hypercholesterolemia is a hereditary genetic disorder predisposing in premature atherosclerosis and cardiovascular complications.The main gap of evidence remains the lack of longitudinal follow up studies investigating cardiovascular outcomes, side effects, and effectiveness of treatment starting from childhood. (2019-01-02)
Is very low LDL-C harmful?
Low-density Lipoprotein Cholesterol (LDL-C) is a major Cardiovascular (CV) risk factor. (2019-01-01)
The role of PCSK9 in the pathogenesis of non-alcoholic fatty liver disease
Data indicates that high intrahepatic or circulating PCSK9 levels increase muscle and liver lipid storage, adipose energy storage and hepatic fatty acids, as well as triglycerides storage and secretion, thus contributing to the pathogenesis of NAFLD. (2019-01-01)
Statins are more effective for those who follow the Mediterranean diet
For those who have already had a heart attack or a stroke, the combination of statins and Mediterranean Diet appears to be the most effective choice to reduce the risk of mortality, especially from cardiovascular causes. (2018-12-21)
Cholesterol-lowering drugs reduce brown adipose tissue
ETH Zurich scientists have shown that statins, one of the most commonly prescribed classes of pharmaceuticals, reduce beneficial brown adipose tissue. (2018-12-21)
Statins have low risk of side effects
Cholesterol-lowering statin drugs are associated with a low risk of side effects. (2018-12-10)
Increasing statins dose and patient adherence could save more lives
Thousands of heart attacks and deaths from cardiovascular disease could be prevented by patients taking higher doses of statins and taking the drugs as advised by doctors. (2018-12-07)
Statins overprescribed for primary prevention
Taking cholesterol-lowering drugs, or statins, as a preventive measure can reduce the risk of cardiovascular disease. (2018-12-06)
SWOG shares trio of studies at San Antonio breast cancer symposium
SWOG Cancer Research Network members will share the results of three studies at the San Antonio Breast Cancer Symposium, an international gathering of breast cancer physicians and researchers that starts today, with an estimated 7,500 attendees expected from more than 90 countries. (2018-12-04)
REDUCE-IT reveals high dose of pure EPA in omega-3 drug cuts risk of cardiovascular events
Results released today from a major clinical trial may have direct implications for patients who remain at increased cardiovascular risk despite taking statin therapy. (2018-11-10)
Page 1 of 24 | 945 Results
   First   Previous   Next      Last   

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Climate Crisis
There's no greater threat to humanity than climate change. What can we do to stop the worst consequences? This hour, TED speakers explore how we can save our planet and whether we can do it in time. Guests include climate activist Greta Thunberg, chemical engineer Jennifer Wilcox, research scientist Sean Davis, food innovator Bruce Friedrich, and psychologist Per Espen Stoknes.
Now Playing: Science for the People

#527 Honey I CRISPR'd the Kids
This week we're coming to you from Awesome Con in Washington, D.C. There, host Bethany Brookshire led a panel of three amazing guests to talk about the promise and perils of CRISPR, and what happens now that CRISPR babies have (maybe?) been born. Featuring science writer Tina Saey, molecular biologist Anne Simon, and bioethicist Alan Regenberg. A Nobel Prize winner argues banning CRISPR babies won’t work Geneticists push for a 5-year global ban on gene-edited babies A CRISPR spin-off causes unintended typos in DNA News of the first gene-edited babies ignited a firestorm The researcher who created CRISPR twins defends...